WebSep 4, 2024 · LE013 - Disrupting hDot1L and MLL Oncofusion Protein Interactions as a Novel Therapeutic Strategy Prof. Zaneta NIKOLOVSKA-COLESKA UNIVERSITY OF … WebMar 7, 2003 · The full-length hDOT1L consists of 1537 amino acids (Feng et al., 2002), but only the N-terminal ∼360 amino acids share significant sequence similarity with yeast …
EFMC-ISMC 2024 Scientific Programme
WebApr 22, 2005 · The above results have two possible explanations. The first is that the mutant hDOT1L may have a general role in suppression of cell growth. Alternatively, the mutant … WebThe disulfide-linked analog of mono-ubiquitylated H2B stimulated the H3K79 methyltransferase activity of hDot1L to a similar extent as the native isopeptide linkage. This permitted structure-activity studies of ubiquitylated mononucleosomes that revealed plasticity in the mechanism of hDot1L stimulation and identified surfaces of ubiquitin ... the source beaches
Structure of the Catalytic Domain of Human DOT1L, a Non-SET …
WebMay 12, 2015 · It remains to be investigated if hDot1L in such a complex is still distributive or constitutes a pseudo-processive mechanism. Indeed, hDot1L and RNA polymerase II colocalize at transcription start sites, where H3K79me2 is enriched 6,8,58,60 and recruitment of hDot1L to H3K9-acetylated chromatin through AF9 correlates with the … WebMay 11, 2005 · Zhang's study reveals that leukemia cells containing MLL-AF10 require hDOT1L to survive. When the researchers introduced into leukemia cells a defective form of hDOT1L, one that cannot methylate histone proteins, the cells were no longer able to grow. "This study highlights the potential of hDOT1L as a possible drug target," Zhang added. WebNov 28, 2024 · OBJECTIVE The purpose of this study was to investigate the possible mechanism of hDOT1L in the pathogenesis of leukemia.We explored the effect of a small interfering RNA(siRNA),which could silence ... myrtle ground cover with ferns